Silvia Sánchez-García1, Javier Ruiz-Hornillos2,3,4, Carmelo Escudero1. 1. Allergy Department, Hospital Infantil Universitario Niño Jesús and ARADyAL-RETICs Network, Instituto de Salud Carlos III, Madrid, Spain. 2. Allergy Department, Hospital Infanta Elena, Valdemoro, Spain. 3. Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain. 4. Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD), Madrid, Spain.
Abstract
Background: During the COVID-19 pandemic specialists were concerned about how to achieve the best control of pediatric asthmatic patients. Methods: A national survey was performed. Analysis of the mean of follow-up, complementary tests, health system (public/private/both), availability of severe asthma units, and geographic location (cities with high COVID-19 prevalence vs. other cities with low prevalence). Differences were analyzed using contingency tables and Pearson's chi-squared test. Results: We obtained 95 responses, mostly from cities with a high disease prevalence (39; 52%). Only 29 (38.6%) of respondents provided care in a severe asthma unit. Severe asthmatic children were followed up mainly by telephone (68; 90.7%) and by in-person visits (32; 42.7%). Face-to-face care was less frequent in cities with a high prevalence of COVID-19 when compared with smaller cities (P = 0.044). Some of the surveyed physicians had discontinued patient follow-up as they were caring for patients with COVID-19 (7; 9.3%). Of all specialists surveyed, 45.3% did not evaluate severe asthmatic children with any means of testing. Pulmonary function tests were scarcely implemented. Blood tests were the most common test performed (45.3%). Specialists working in a severe asthma unit carried out more pulmonary function tests (P = 0.019). Peculiarly, moderate persistent asthmatics underwent more spirometries in cities with a high prevalence rate (P = 0.03). Follow-up of asthmatic children during the pandemic was perceived to be reduced or altogether inexistent by 42.7% of respondents when compared with a similar season outside of this emergency situation. Remarkably, the perception that better management of asthma was delivered during the pandemic by those working in cities with a high prevalence of COVID-19 versus other regions. Conclusions: Pediatric asthma control is crucial to decrease the future risk presented by the condition. New technologies and severe asthma units may become key tools in global health emergencies such as the COVID-19 pandemic.
Background: During the COVID-19 pandemic specialists were concerned about how to achieve the best control of pediatric asthmatic patients. Methods: A national survey was performed. Analysis of the mean of follow-up, complementary tests, health system (public/private/both), availability of severe asthma units, and geographic location (cities with high COVID-19 prevalence vs. other cities with low prevalence). Differences were analyzed using contingency tables and Pearson's chi-squared test. Results: We obtained 95 responses, mostly from cities with a high disease prevalence (39; 52%). Only 29 (38.6%) of respondents provided care in a severe asthma unit. Severe asthmatic children were followed up mainly by telephone (68; 90.7%) and by in-person visits (32; 42.7%). Face-to-face care was less frequent in cities with a high prevalence of COVID-19 when compared with smaller cities (P = 0.044). Some of the surveyed physicians had discontinued patient follow-up as they were caring for patients with COVID-19 (7; 9.3%). Of all specialists surveyed, 45.3% did not evaluate severe asthmatic children with any means of testing. Pulmonary function tests were scarcely implemented. Blood tests were the most common test performed (45.3%). Specialists working in a severe asthma unit carried out more pulmonary function tests (P = 0.019). Peculiarly, moderate persistent asthmatics underwent more spirometries in cities with a high prevalence rate (P = 0.03). Follow-up of asthmatic children during the pandemic was perceived to be reduced or altogether inexistent by 42.7% of respondents when compared with a similar season outside of this emergency situation. Remarkably, the perception that better management of asthma was delivered during the pandemic by those working in cities with a high prevalence of COVID-19 versus other regions. Conclusions: Pediatric asthma control is crucial to decrease the future risk presented by the condition. New technologies and severe asthma units may become key tools in global health emergencies such as the COVID-19 pandemic.
Entities:
Keywords:
COVID-19; eHealth; pediatric asthma; severe asthma; telemedicine
Authors: Paolo Maria Matricardi; Stephanie Dramburg; Alberto Alvarez-Perea; Darío Antolín-Amérigo; Christian Apfelbacher; Marina Atanaskovic-Markovic; Uwe Berger; Michael S Blaiss; Simon Blank; Elisa Boni; Matteo Bonini; Jean Bousquet; Knut Brockow; Jeroen Buters; Victoria Cardona; Jean-Christoph Caubet; Özlem Cavkaytar; Tania Elliott; Ignacio Esteban-Gorgojo; Joao A Fonseca; James Gardner; Philippe Gevaert; Ileana Ghiordanescu; Peter Hellings; Karin Hoffmann-Sommergruber; A Fusun Kalpaklioglu; Farid Marmouz; Ángela Meijide Calderón; Ralph Mösges; Alla Nakonechna; Markus Ollert; José Oteros; Giovanni Pajno; Catalina Panaitescu; Daniel Perez-Formigo; Oliver Pfaar; Constantinos Pitsios; Michael Rudenko; Dermot Ryan; Silvia Sánchez-García; Jennifer Shih; Salvatore Tripodi; Lauri-Ann Van der Poel; Harmieke van Os-Medendorp; Gilda Varricchi; Jörn Wittmann; Margitta Worm; Ioana Agache Journal: Allergy Date: 2019-09-16 Impact factor: 13.146
Authors: I Fernández-de-Alba; C Brigido; I García-Gutierrez; D Antolín-Amérigo; S Sánchez-García Journal: J Investig Allergol Clin Immunol Date: 2020-07-02 Impact factor: 4.333
Authors: Nadia L Krupp; Andrea Weist; Cindy D Fiscus; James Slaven; Andrew Harner; Gregory S Montgomery; Michelle S Howenstine Journal: Pediatr Pulmonol Date: 2018-02-27
Authors: Helen A Brough; Omer Kalayci; Anna Sediva; Eva Untersmayr; Daniel Munblit; Pablo Rodriguez Del Rio; Marta Vazquez-Ortiz; Stefania Arasi; Montserrat Alvaro-Lozano; Sophia Tsabouri; Elena Galli; Burcin Beken; Philippe A Eigenmann Journal: Pediatr Allergy Immunol Date: 2020-05-31 Impact factor: 5.464
Authors: Marcus S Shaker; John Oppenheimer; Mitchell Grayson; David Stukus; Nicholas Hartog; Elena W Y Hsieh; Nicholas Rider; Cullen M Dutmer; Timothy K Vander Leek; Harold Kim; Edmond S Chan; Doug Mack; Anne K Ellis; David Lang; Jay Lieberman; David Fleischer; David B K Golden; Dana Wallace; Jay Portnoy; Giselle Mosnaim; Matthew Greenhawt Journal: J Allergy Clin Immunol Pract Date: 2020-03-26